Peyer's Patches are Required for Oral Tolerance to Proteins

To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin β-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunizati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2001-03, Vol.98 (6), p.3310-3315
Hauptverfasser: Fujihashi, Kohtaro, Dohi, Taeko, Rennert, Paul D., Yamamoto, Masafumi, Koga, Toshiya, Kiyono, Hiroshi, McGhee, Jerry R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3315
container_issue 6
container_start_page 3310
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 98
creator Fujihashi, Kohtaro
Dohi, Taeko
Rennert, Paul D.
Yamamoto, Masafumi
Koga, Toshiya
Kiyono, Hiroshi
McGhee, Jerry R.
description To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin β-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunization, OVA-specific IgG Ab responses in serum and spleen were seen, in marked contrast to low responses in OVA-fed normal mice. Further, high T-cell-proliferative- and delayed-type hypersensitivity responses were seen in Peyer's patch-null mice given oral OVA before systemic challenge. Higher levels of CD4+ T-cell-derived IFN-γ, IL-4, IL-5, and IL-10 syntheses were noted in Peyer's patch-null mice fed OVA, whereas OVA-fed normal mice had suppressed cytokine levels. In contrast, oral administration of trinitrobenzene sulfonic acid (TNBS) to Peyer's patch-null mice resulted in reduced TNBS-specific serum Abs and splenic B cell antitrinitrophenyl Ab-forming cell responses after skin painting with picryl chloride. Further, when delayed-type hypersensitivity and splenic T cell proliferative responses were examined, Peyer's patch-null mice fed TNBS were unresponsive to hapten. Peyer's patch-null mice fed trinitrophenyl-OVA failed to induce systemic unresponsiveness to hapten or protein. These findings show that organized Peyer's patches are required for oral tolerance to proteins, whereas haptens elicit systemic unresponsiveness via the intestinal epithelial cell barrier.
doi_str_mv 10.1073/pnas.061412598
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_201382133</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3055232</jstor_id><sourcerecordid>3055232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c582t-5a1f975042ccf65b0a42adeda594f0126d75c54bde963433690cd6f9717d02bf3</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxS1ERUPhygnQigM9bRh_rq1yQRUUpEqNUDlbjneWbrRZp7YX0f8eRwlp4QCnObzfG72ZR8gLCnMKDX-3GV2ag6KCMmn0IzKjYGithIHHZAbAmloLJo7J05RWAGCkhifkmFImNDRyRs4WeIfxNFULl_0NpspFrL7i7dRHbKsuxOoquqG6DgNGN3qscqgWMWTsx_SMHHVuSPh8P0_It08fr88_15dXF1_OP1zWXmqWa-loZxoJgnnfKbkEJ5hrsXXSiA4oU20jvRTLFo3ignNlwLeqWGjTAlt2_IS83-3dTMs1th7HXDLZTezXLt7Z4Hr7pzL2N_Z7-GE5KAnF_nZvj-F2wpTtuk8eh8GNGKZkG2UaphX9L0g1UE4VK-Cbv8BVmOJYfmBZQTSjnBdovoN8DClF7A6BKdhtd3bbnT10VwyvH555j-_LepBva_wtG22V5bws7aZhyPgzF_DVv8Civ9zpq5RDPAAcpGSc8V-4MLT0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201382133</pqid></control><display><type>article</type><title>Peyer's Patches are Required for Oral Tolerance to Proteins</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Fujihashi, Kohtaro ; Dohi, Taeko ; Rennert, Paul D. ; Yamamoto, Masafumi ; Koga, Toshiya ; Kiyono, Hiroshi ; McGhee, Jerry R.</creator><creatorcontrib>Fujihashi, Kohtaro ; Dohi, Taeko ; Rennert, Paul D. ; Yamamoto, Masafumi ; Koga, Toshiya ; Kiyono, Hiroshi ; McGhee, Jerry R.</creatorcontrib><description>To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin β-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunization, OVA-specific IgG Ab responses in serum and spleen were seen, in marked contrast to low responses in OVA-fed normal mice. Further, high T-cell-proliferative- and delayed-type hypersensitivity responses were seen in Peyer's patch-null mice given oral OVA before systemic challenge. Higher levels of CD4+ T-cell-derived IFN-γ, IL-4, IL-5, and IL-10 syntheses were noted in Peyer's patch-null mice fed OVA, whereas OVA-fed normal mice had suppressed cytokine levels. In contrast, oral administration of trinitrobenzene sulfonic acid (TNBS) to Peyer's patch-null mice resulted in reduced TNBS-specific serum Abs and splenic B cell antitrinitrophenyl Ab-forming cell responses after skin painting with picryl chloride. Further, when delayed-type hypersensitivity and splenic T cell proliferative responses were examined, Peyer's patch-null mice fed TNBS were unresponsive to hapten. Peyer's patch-null mice fed trinitrophenyl-OVA failed to induce systemic unresponsiveness to hapten or protein. These findings show that organized Peyer's patches are required for oral tolerance to proteins, whereas haptens elicit systemic unresponsiveness via the intestinal epithelial cell barrier.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.061412598</identifier><identifier>PMID: 11248075</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Administration, Oral ; Animals ; B lymphocytes ; B-Lymphocytes - immunology ; Biological Sciences ; Cytokines ; Cytokines - biosynthesis ; Dams ; Female ; g-Interferon ; Haptens ; Haptens - immunology ; Immune Tolerance - immunology ; Immunization ; Immunology ; Lymphotoxin beta Receptor ; Mice ; Mice, Inbred BALB C ; Oral administration ; Ova ; Ovalbumin - administration &amp; dosage ; Ovalbumin - blood ; Ovalbumin - immunology ; Peyer's Patches - immunology ; Peyers patches ; Proteins ; Receptors, Tumor Necrosis Factor - genetics ; Receptors, Tumor Necrosis Factor - immunology ; Rodents ; T lymphocytes ; T-Lymphocytes - immunology ; Th1 Cells - immunology ; Th2 Cells - immunology ; Trinitrobenzenesulfonic Acid - immunology</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (6), p.3310-3315</ispartof><rights>Copyright 1993-2001 National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences Mar 13, 2001</rights><rights>Copyright © 2001, The National Academy of Sciences 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c582t-5a1f975042ccf65b0a42adeda594f0126d75c54bde963433690cd6f9717d02bf3</citedby><cites>FETCH-LOGICAL-c582t-5a1f975042ccf65b0a42adeda594f0126d75c54bde963433690cd6f9717d02bf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/98/6.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3055232$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3055232$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11248075$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujihashi, Kohtaro</creatorcontrib><creatorcontrib>Dohi, Taeko</creatorcontrib><creatorcontrib>Rennert, Paul D.</creatorcontrib><creatorcontrib>Yamamoto, Masafumi</creatorcontrib><creatorcontrib>Koga, Toshiya</creatorcontrib><creatorcontrib>Kiyono, Hiroshi</creatorcontrib><creatorcontrib>McGhee, Jerry R.</creatorcontrib><title>Peyer's Patches are Required for Oral Tolerance to Proteins</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin β-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunization, OVA-specific IgG Ab responses in serum and spleen were seen, in marked contrast to low responses in OVA-fed normal mice. Further, high T-cell-proliferative- and delayed-type hypersensitivity responses were seen in Peyer's patch-null mice given oral OVA before systemic challenge. Higher levels of CD4+ T-cell-derived IFN-γ, IL-4, IL-5, and IL-10 syntheses were noted in Peyer's patch-null mice fed OVA, whereas OVA-fed normal mice had suppressed cytokine levels. In contrast, oral administration of trinitrobenzene sulfonic acid (TNBS) to Peyer's patch-null mice resulted in reduced TNBS-specific serum Abs and splenic B cell antitrinitrophenyl Ab-forming cell responses after skin painting with picryl chloride. Further, when delayed-type hypersensitivity and splenic T cell proliferative responses were examined, Peyer's patch-null mice fed TNBS were unresponsive to hapten. Peyer's patch-null mice fed trinitrophenyl-OVA failed to induce systemic unresponsiveness to hapten or protein. These findings show that organized Peyer's patches are required for oral tolerance to proteins, whereas haptens elicit systemic unresponsiveness via the intestinal epithelial cell barrier.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>B lymphocytes</subject><subject>B-Lymphocytes - immunology</subject><subject>Biological Sciences</subject><subject>Cytokines</subject><subject>Cytokines - biosynthesis</subject><subject>Dams</subject><subject>Female</subject><subject>g-Interferon</subject><subject>Haptens</subject><subject>Haptens - immunology</subject><subject>Immune Tolerance - immunology</subject><subject>Immunization</subject><subject>Immunology</subject><subject>Lymphotoxin beta Receptor</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Oral administration</subject><subject>Ova</subject><subject>Ovalbumin - administration &amp; dosage</subject><subject>Ovalbumin - blood</subject><subject>Ovalbumin - immunology</subject><subject>Peyer's Patches - immunology</subject><subject>Peyers patches</subject><subject>Proteins</subject><subject>Receptors, Tumor Necrosis Factor - genetics</subject><subject>Receptors, Tumor Necrosis Factor - immunology</subject><subject>Rodents</subject><subject>T lymphocytes</subject><subject>T-Lymphocytes - immunology</subject><subject>Th1 Cells - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Trinitrobenzenesulfonic Acid - immunology</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1vEzEQxS1ERUPhygnQigM9bRh_rq1yQRUUpEqNUDlbjneWbrRZp7YX0f8eRwlp4QCnObzfG72ZR8gLCnMKDX-3GV2ag6KCMmn0IzKjYGithIHHZAbAmloLJo7J05RWAGCkhifkmFImNDRyRs4WeIfxNFULl_0NpspFrL7i7dRHbKsuxOoquqG6DgNGN3qscqgWMWTsx_SMHHVuSPh8P0_It08fr88_15dXF1_OP1zWXmqWa-loZxoJgnnfKbkEJ5hrsXXSiA4oU20jvRTLFo3ignNlwLeqWGjTAlt2_IS83-3dTMs1th7HXDLZTezXLt7Z4Hr7pzL2N_Z7-GE5KAnF_nZvj-F2wpTtuk8eh8GNGKZkG2UaphX9L0g1UE4VK-Cbv8BVmOJYfmBZQTSjnBdovoN8DClF7A6BKdhtd3bbnT10VwyvH555j-_LepBva_wtG22V5bws7aZhyPgzF_DVv8Civ9zpq5RDPAAcpGSc8V-4MLT0</recordid><startdate>20010313</startdate><enddate>20010313</enddate><creator>Fujihashi, Kohtaro</creator><creator>Dohi, Taeko</creator><creator>Rennert, Paul D.</creator><creator>Yamamoto, Masafumi</creator><creator>Koga, Toshiya</creator><creator>Kiyono, Hiroshi</creator><creator>McGhee, Jerry R.</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><general>The National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20010313</creationdate><title>Peyer's Patches are Required for Oral Tolerance to Proteins</title><author>Fujihashi, Kohtaro ; Dohi, Taeko ; Rennert, Paul D. ; Yamamoto, Masafumi ; Koga, Toshiya ; Kiyono, Hiroshi ; McGhee, Jerry R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c582t-5a1f975042ccf65b0a42adeda594f0126d75c54bde963433690cd6f9717d02bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>B lymphocytes</topic><topic>B-Lymphocytes - immunology</topic><topic>Biological Sciences</topic><topic>Cytokines</topic><topic>Cytokines - biosynthesis</topic><topic>Dams</topic><topic>Female</topic><topic>g-Interferon</topic><topic>Haptens</topic><topic>Haptens - immunology</topic><topic>Immune Tolerance - immunology</topic><topic>Immunization</topic><topic>Immunology</topic><topic>Lymphotoxin beta Receptor</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Oral administration</topic><topic>Ova</topic><topic>Ovalbumin - administration &amp; dosage</topic><topic>Ovalbumin - blood</topic><topic>Ovalbumin - immunology</topic><topic>Peyer's Patches - immunology</topic><topic>Peyers patches</topic><topic>Proteins</topic><topic>Receptors, Tumor Necrosis Factor - genetics</topic><topic>Receptors, Tumor Necrosis Factor - immunology</topic><topic>Rodents</topic><topic>T lymphocytes</topic><topic>T-Lymphocytes - immunology</topic><topic>Th1 Cells - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Trinitrobenzenesulfonic Acid - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujihashi, Kohtaro</creatorcontrib><creatorcontrib>Dohi, Taeko</creatorcontrib><creatorcontrib>Rennert, Paul D.</creatorcontrib><creatorcontrib>Yamamoto, Masafumi</creatorcontrib><creatorcontrib>Koga, Toshiya</creatorcontrib><creatorcontrib>Kiyono, Hiroshi</creatorcontrib><creatorcontrib>McGhee, Jerry R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujihashi, Kohtaro</au><au>Dohi, Taeko</au><au>Rennert, Paul D.</au><au>Yamamoto, Masafumi</au><au>Koga, Toshiya</au><au>Kiyono, Hiroshi</au><au>McGhee, Jerry R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peyer's Patches are Required for Oral Tolerance to Proteins</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2001-03-13</date><risdate>2001</risdate><volume>98</volume><issue>6</issue><spage>3310</spage><epage>3315</epage><pages>3310-3315</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>To clarify the role of Peyer's patches in oral tolerance induction, BALB/c mice were treated in utero with lymphotoxin β-receptor Ig fusion protein to generate mice lacking Peyer's patches. When these Peyer's patch-null mice were fed 25 mg of ovalbumin (OVA) before systemic immunization, OVA-specific IgG Ab responses in serum and spleen were seen, in marked contrast to low responses in OVA-fed normal mice. Further, high T-cell-proliferative- and delayed-type hypersensitivity responses were seen in Peyer's patch-null mice given oral OVA before systemic challenge. Higher levels of CD4+ T-cell-derived IFN-γ, IL-4, IL-5, and IL-10 syntheses were noted in Peyer's patch-null mice fed OVA, whereas OVA-fed normal mice had suppressed cytokine levels. In contrast, oral administration of trinitrobenzene sulfonic acid (TNBS) to Peyer's patch-null mice resulted in reduced TNBS-specific serum Abs and splenic B cell antitrinitrophenyl Ab-forming cell responses after skin painting with picryl chloride. Further, when delayed-type hypersensitivity and splenic T cell proliferative responses were examined, Peyer's patch-null mice fed TNBS were unresponsive to hapten. Peyer's patch-null mice fed trinitrophenyl-OVA failed to induce systemic unresponsiveness to hapten or protein. These findings show that organized Peyer's patches are required for oral tolerance to proteins, whereas haptens elicit systemic unresponsiveness via the intestinal epithelial cell barrier.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>11248075</pmid><doi>10.1073/pnas.061412598</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (6), p.3310-3315
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_journals_201382133
source Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Administration, Oral
Animals
B lymphocytes
B-Lymphocytes - immunology
Biological Sciences
Cytokines
Cytokines - biosynthesis
Dams
Female
g-Interferon
Haptens
Haptens - immunology
Immune Tolerance - immunology
Immunization
Immunology
Lymphotoxin beta Receptor
Mice
Mice, Inbred BALB C
Oral administration
Ova
Ovalbumin - administration & dosage
Ovalbumin - blood
Ovalbumin - immunology
Peyer's Patches - immunology
Peyers patches
Proteins
Receptors, Tumor Necrosis Factor - genetics
Receptors, Tumor Necrosis Factor - immunology
Rodents
T lymphocytes
T-Lymphocytes - immunology
Th1 Cells - immunology
Th2 Cells - immunology
Trinitrobenzenesulfonic Acid - immunology
title Peyer's Patches are Required for Oral Tolerance to Proteins
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T20%3A55%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peyer's%20Patches%20are%20Required%20for%20Oral%20Tolerance%20to%20Proteins&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Fujihashi,%20Kohtaro&rft.date=2001-03-13&rft.volume=98&rft.issue=6&rft.spage=3310&rft.epage=3315&rft.pages=3310-3315&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.061412598&rft_dat=%3Cjstor_proqu%3E3055232%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201382133&rft_id=info:pmid/11248075&rft_jstor_id=3055232&rfr_iscdi=true